Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals, India, Distributed by: Amneal Pharmaceuticals, Bridgewater, NJ, NDC 65162-755-10
Published August 31, 2022 · Recall initiated: July 27, 2022
Summary
FDA records drug Class II recall D-1362-2022, published August 31, 2022 and initiated July 27, 2022. Recalling firm: Amneal Pharmaceuticals of New York, LLC; Status: Terminated; Reported quantity: 4,309 bottles; Lot: Lot #: AR210705, Exp 04/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email if DIVALPROEX SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIVALPROEX SODIUM
- Manufacturer
- Amneal Pharmaceuticals of New York, LLC
- Distributor
- USA nationwide
- UPC
- 0365162755107
- Lot
- Lot #: AR210705, Exp 04/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADivalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by:July 29, 2026
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: AmnealApril 3, 2024
- FDANovelty Hand Sanitizer with Silicone Wrap SKU 998890 Novelty Hand Sanitizer Assorted SKU 999330 Purell HandAugust 31, 2022
- FDAEchelon -14, 45 Tip Shape, REF 145-5092150, sterile EO, Rx OnlyAugust 24, 2022
- FDADivalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun PharmaceuticalAugust 3, 2022
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy'sFebruary 27, 2019
Questions about this recall
Was Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals, India, Distributed by: Amneal Pharmaceuticals, Bridgewater, NJ, NDC 65162-755-10 recalled?
Yes. FDA published recall D-1362-2022 on August 31, 2022. Reported hazard: Failed dissolution specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIVALPROEX SODIUM. UPC: 0365162755107.